Mirae Asset Global Etfs Holdings Ltd. Sarepta Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 42,450 shares of SRPT stock, worth $961,068. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,450
Previous 28,829
47.25%
Holding current value
$961,068
Previous $1.84 Million
60.58%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SRPT
# of Institutions
462Shares Held
83.3MCall Options Held
5.6MPut Options Held
4.19M-
Black Rock Inc. New York, NY10.3MShares$234 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$207 Million0.0% of portfolio
-
State Street Corp Boston, MA4.7MShares$106 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.48MShares$101 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA2.53MShares$57.3 Million0.01% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.98B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...